Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ADMA
#1300
ADMA Biologics, Inc.
15.5
7
+5.49%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+5.49%
Monthly Change
-5.98%
6 month change
-10.05%
Year Change
+1.43%
Previous Close
14.7
6
Open
15.5
7
Bid
Ask
Low
15.5
7
High
15.5
7
Volume
204
Markets
US Stock Market
Healthcare
ADMA
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
ADMA Biologics Inc earnings beat by $0.03, revenue fell short of estimates
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
Adam Grossman, president of Adma Biologics, sells $337,679 in shares
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know